Improved Metabolism: Can enhance metabolic rates without impacting blood sugar levels
The interstitial cystitis & bladder pain syndrome (IC/BPS) treatment market is expected to benefit from advancements in precision medicine, regenerative therapies, AI-assisted diagnostics, novel biologics, and sustained-release drug delivery systems, creating opportunities for personalized treatment, improved patient outcomes, and expanded access in emerging healthcare markets
Research has identified 160 genes that are synergistically regulated by the combined action of IL-17 and TNF-alpha, meaning these two cytokines together produce effects far greater than either one alone
Most patients land somewhere between 5 mg and 15 mg as their maintenance dose 15 mg is the ceiling
Does OrderlyMeds accept insurance or HSA/FSA
Most previous options in this category only targeted GLP-1